Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis ...
An international team of researchers led by Professor Dr. Lucas Schirmer and Professor Dr. Julio Saez-Rodriguez from the ...
Most cancer treatments—from chemotherapies to engineered immune cells—have a host of side effects, in large part because they ...
Contineum has two drug candidates in clinical trials, PIPE-791, an LPA1 receptor antagonist in clinical development for ...
Two enzymes in brain cells are responsible for mediating the toxic effects of certain fat molecules in multiple sclerosis, ...
The global artificial intelligence (AI) in drug discovery market is projected to reach USD 6.89 billion by 2029 from USD 1.86 ...
Concluded targeted enrollment of Phase 3 INDIGO trial evaluating obexelimab for the treatment of Immunoglobulin G4-Related ...
Leerink Partners analyst Faisal Khurshid reiterated a Buy rating on Immunic (IMUX – Research Report) on November 7 and set a price target ...
Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback